What are you looking for?

Wound Care Human

These Products are Currently Under development

Human Wound & Infection Treatments

SoftOx is developing a range of products that can be classified as either medical devices or medicinal products (drugs) for human use. Collectively, our research and development efforts focus on the prevention and eradication of serious infections. Such infections are not limited to pathogenic bacteria, but may also include viral and fungal infections. Our current product candidates are either in the clinical or late pre-clinical (animal testing) phase.

  • SoftOx Wound Irrigation Solutions (medical device) for acute and chronic wounds, to prevent and treat infections (including biofilms).
  • SoftOx Anti-infectives are products aimed at actively treat and remove topical infections in wounded and mucosal tissues, such as those caused by biofilms, AMR microbes, viruses and fungi.
Scientific publications

Burain et al (2022): Effect of stabilized hypochlorous acid on re-epithelialization and bacterial bioburden in acute wounds: A randomized controlled trial in healthy volunteers

Purpose:

The aim of this randomized controlled trial was to evaluate the wound-healing effect and antimicrobial properties of a novel stabilized hypochlorous acid solution on acute wounds, using a suction blister wound model.

Download here

Burain et al (2021): The safety and antimicrobial properties of stabilized hypochlorous acid in acetic acid buffer for the treatment of acute wounds—a human pilot study and in vitro data

Purpose:

A first-in-man, prospective, open-label, exploratory pilot study to document the preliminary safety and performance of HOCl+buffer for topical use when used on acute wounds.

“Future practical solutions for fighting antimicrobial resistance in wound care”

EWMA Conference 2022 symposium

The European Wound Management Association (EWMA) is a not-for-profit umbrella organisation, linking national wound management organisations, individuals and groups with interest in wound care. At the EWMA Conference 2022, SoftOx hosted an educational symposium titled ‘Future practical solutions for fighting antimicrobial resistance in wound care’.

Speakers and agenda:
  • Prof. Niels Frimodt-Møller (Rigshospitalet, Dept. of Clinical Microbiology,
    Copenhagen, DK)
    Antimicrobial resistance in your practice: an ever more powerful adversary
  • Prof. Thomas Bjarnsholt (Copenhagen University Hospital, Dept. of Clinical
    Microbiology, Copenhagen, DK)
    Countering antimicrobial resistance: its history and mechanism of action
  • Dr. Klaus Kirketerp-Møller (Wound Healing Center, Bispebjerg University
    Hospital, Copenhagen, DK)
    Fighting antimicrobial resistance in wound care tomorrow: clinical research
    today

Watch the recording here